A complete list of publications by Dr Eunice Nduati. Use the filters to refine by year, journal or keyword.

No publications match those filters.

1. 2025
   Unique genetic signatures in HIV-1 subtype A1 and A1D recombinant envelope glycoprotein distinguish contemporary transmitted/founder viruses from historical strains in East Africa

   Kato, F. Kapaata, A. Galiwango, R. Nakyanzi, et al.

   Front Microbiol. 2025; 16:1632581

   View abstract DOI PubMed
2. 2025
   Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa

   Chanda, C. Kibengo, F. Mutua, M. Ogada, et al.

   Lancet Microbe. 2025; 6:101041

   View abstract DOI PubMed
3. 2025
   Validation of high-throughput oxford nanopore technology for HIV-1 transmitted/founder virus identification

   Byamukama, D. Ndekezi, C. Omara, D. Nakyanzi, et al.

   Int J Infect Dis. 2025; 161:108138

   View abstract DOI PubMed
4. 2025
   Advancing the course of HIV genomics research in Africa

   Agamah, F. E. Arbuthnot, P. Tindana, P. Munung, et al.

   BMJ Glob Health. 2025; 10

   View abstract DOI PubMed
5. 2024
   Profiling IgG and IgA antibody responses during vaccination and infection in a high-risk gonorrhoea population

   Stejskal, L. Thistlethwaite, A. Ramirez-Bencomo, F. Rashmi, et al.

   Nat Commun. 2024; 15:6712

   View abstract DOI PubMed
6. 2024
   Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya

   Lugano, D. Kutima, B. Kimani, M. Sigilai, et al.

   BMC Infect Dis. 2024; 24:1474

   View abstract DOI PubMed
7. 2023
   Exposure to common infections may shape basal immunity and potentially HIV-1 acquisition amongst a high-risk population in Coastal Kenya

   Fwambah, L. Andisi, C. Streatfield, C. Bromell, et al.

   Front Immunol. 2023; 14:1283559

   View abstract DOI PubMed
8. 2023
   Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro

   Nyagwange, J. Kutima, B. Mwai, K. Karanja, et al.

   Int J Infect Dis. 2023; 127:11-16

   View abstract DOI PubMed
9. 2022
   Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay

   Fernandez, N. Hayes, P. Makinde, J. Hare, et al.

   Front Immunol. 2022; 13:1029029

   View abstract DOI PubMed
10. 2021
    Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans

    Sutton, H. J. Aye, R. Idris, A. H. Vistein, et al.

    Cell Rep. 2021; 34:108684

    View abstract DOI PubMed
11. 2019
    Symptom-based Scoring for Acute Human Immunodeficiency Virus

    Sanders, E. J. Kigoro, A. Thiong'o, A. Nduati, et al.

    Clin Infect Dis. 2019; 69:736-737

    View abstract DOI PubMed
12. 2017
    Cytomegalovirus viraemia is associated with poor growth and T-cell activation with an increased burden in HIV-exposed uninfected infants

    Garcia-Knight, M. A. Nduati, E. Hassan, A. S. Nkumama, et al.

    AIDS. 2017; 31:1809-1818

    View abstract DOI PubMed
13. 2015
    Altered Memory T-Cell Responses to Bacillus Calmette-Guerin and Tetanus Toxoid Vaccination and Altered Cytokine Responses to Polyclonal Stimulation in HIV-Exposed Uninfected Kenyan Infants

    Garcia-Knight, M. A. Nduati, E. Hassan, A. S. Gambo, et al.

    PLoS One. 2015; 10:e0143043

    View abstract DOI PubMed
14. 2014
    HIV-exposed uninfected children: a growing population with a vulnerable immune system?

    Afran, L. Garcia Knight, M. Nduati, E. Urban, et al.

    Clin Exp Immunol. 2014; 176:11-22

    View abstract DOI PubMed
15. 2011
    The plasma concentration of the B cell activating factor is increased in children with acute malaria

    Nduati, E. Gwela, A. Karanja, H. Mugyenyi, et al.

    J Infect Dis. 2011; 204:962-70

    View abstract DOI PubMed
16. 2008
    Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer

    Nduati, E. Diriye, A. Ommeh, S. Mwai, et al.

    Parasitol Res. 2008; 102:1227-34

    View abstract DOI PubMed
17. 2005
    Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?

    Nzila, A. Ochong, E. Nduati, E. Gilbert, et al.

    Trans R Soc Trop Med Hyg. 2005; 99:341-6

    View abstract DOI PubMed
18. 2005
    2,4-diaminopteridine-based compounds as precursors for de novo synthesis of antifolates: a novel class of antimalarials

    Nduati, E. Hunt, S. Kamau, E. M. Nzila, et al.

    Antimicrob Agents Chemother. 2005; 49:3652-7

    View abstract DOI PubMed
19. 2004
    In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum

    Ommeh, S. Nduati, E. Mberu, E. Kokwaro, et al.

    Antimicrob Agents Chemother. 2004; 48:3711-4

    View abstract DOI PubMed
20. 2002
    Genetic diversity of Plasmodium falciparum parasites from Kenya is not affected by antifolate drug selection

    Nzila, A. M. Mberu, E. K. Nduati, E. Ross, et al.

    Int J Parasitol. 2002; 32:1469-76

    View abstract DOI PubMed
21. 2002
    Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance

    Mberu, E. K. Nzila, A. M. Nduati, E. Ross, et al.

    Exp Parasitol. 2002; 101:90-6

    View abstract DOI PubMed
22. 2001
    Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania

    Mutabingwa, T. Nzila, A. Mberu, E. Nduati, et al.

    Lancet. 2001; 358:1218-23

    View abstract DOI PubMed
23. 2000
    Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum

    Nzila, A. M. Nduati, E. Mberu, E. K. Hopkins Sibley, et al.

    J Infect Dis. 2000; 181:2023-8

    View abstract DOI PubMed